(888) 552-6760 SCHEDULE AN APPOINTMENT

Firoozeh Sahebi,

Hematologist

Biography photo
Location
Duarte Comprehensive Cancer Center
1500 East Duarte Road
Duarte, CA 91010
Specialties
Hematologic Oncology
Education
Medical school:
Board Certifications
  • American Board of Hematology

Degrees
  • 1987, M.D., Tehran University, School of Medicine, Tehran, Iran

Fellowship
  • 1992-1994, Divisions of Hematology /Oncology, UCLA Medical Center, Los Angeles, CA

  • 1991-1992, Divisions of Hematology/ Oncology, Columbia University, College of Physicians & Surgeons, Presbyterian Hospital, New York, NY

Residency
  • 1988-1991, Nassau County Medical Center, Affiliate of State University of New York at Stony Brook, New York, NY

Professional Experience
  • 1998-present, Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

  • 1994-present, Staff Physician, Division of Bone Transplantation and Hematology/Oncology, Kaiser Hospital, Los Angeles, CA

Academic Appointments
  • Professor, Department of Hematology & Hematopoietic Cell Transplantation
About Me
Firoozeh Sahebi, M.D., is a board-certified hematologist specializing in Bone Marrow Transplant and Cancer Cellular Immunotherapy.  She is also a member of the City of Hope/Kaiser Bone Marrow Transplantation Team.
 
Dr. Sahebi obtained her medical degree from School of Medicine at Tehran University. She completed her residency in Internal Medicine at Nassau County Medical Center in East Meadow, NY. She then moved on to complete fellowships in Hematology/Oncology at Columbia University and UCLA Medical Center.
 
She is a member of multiple institutional committees at City of Hope and Southern California Kaiser Permanente. She has published  several peer reviewed journals and presented her research at American Society of Hematology and European Society for Blood and Marrow Transplantation meetings. 
 
Dr. Sahebi enjoys spending time with her family, painting, yoga and her book club.
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.